TGFBI and prostate cancer: The improvement in RWPE-1 acinar morphogenesis and the inhibition of TGFBI-induced PC3 and C4-2B cell invasion by exogenous ECM-1 suggests that increased expression of ECM-1 in prostate cancer may be beneficial to patients, whereas the opposite may be true for TGFBI.